Microsoft unveils a tablet it hopes can rival the iPad; Oracle announces earnings early; a key exec departs JC Penny and Carl Icahn gets an ally on the Chesapeake board.
Roger Clemens has been acquitted on all charges by a jury that decided he didn't lie to Congress when he denied using performance-enhancing drugs.
Rajat Gupta leaves the Federal Courthouse in New York City after receiving a guilty verdict on four of six criminal counts in his insider trading trial. CNBC's Bertha Coombs, reports the details.
Sources say UBS is sitting on losses as high as $350 million from the technical difficulties on Facebook's first day of trading. UBS is considering a lawsuit against Nasdaq, reports CNBC's Maria Bartiromo.
Jérôme Kerviel will set foot in a Paris courtroom again on Monday, two years after the former trader was sentenced to three years behind bars and ordered to pay 4.9 billion euros ($6.09 billion) to former employer Société Générale, the Financial Times reports.
Days before shareholders voted on Bank of America’s 2008 purchase of Merrill Lynch, top executives were told the investment firm’s losses would most likely hammer future earnings, the New York Times reports.
According to the Dow Jones, the jury for the trial between Google and Oracle over an alleged patent infringement has ruled in Google's favor, reports CNBC's Jon Fortt.
The FMHR traders discuss the Senate Banking Committee investigating Facebook and the tumbling markets amid ongoing European debt worries. Marko Papic, BCA Research, offers insight.
Facebook and its underwriters were sued by shareholders who claim the defendants hid weakened growth forecasts ahead of the IPO. Sam Rudman, Robbins, Geller, Rudman & Dowd, discusses the class action suit.
The Securities and Exchange Commission has been getting tougher on insider trading on Wall Street, but its potential target may be too wide, The New York Times reports.
JPMorgan Chase’s $2 billion trading loss, which was disclosed on Thursday, could give supporters of tighter industry regulation a huge new piece of ammunition as they fight a last-ditch battle with the banks over new federal rules that may redefine how banks do business. The New York Times reports.
CNBC's Tyler Mathisen reports on the jury in the Oracle vs. Google trial reaching a partial verdict in favor of Oracle.
The makers of a deer antler velvet product are suing Major League Baseball for libel after the league told players to stop taking the performance enhancer so as not to risk testing positive for a steroid that wasn't listed as an ingredient.
A major new rule that has drawn the ire of Wall Street is on track for completion sooner than some bankers had expected, dashing the hopes of financial industry lobbyists, who have pressed for a delay. The NYT reports.
In a wake of a warning letter sent to them by the FDA, some companies whose pre-workout or weight loss products include the ingredient DMAA, are starting to move on with life without it.
A warning letter written by the Food & Drug Administration last week to ten companies that produce pre-workout supplements with the ingredient dimethylamyamine (DMAA) has sent shockwaves through the industry, not only to the producers of the products but to consumers who have taken them.
CNBC's Kate Kelly reports that Chesapeake Energy is down about 10 percent this week since CEO Aubrey McClendon and his board were sued by a shareholder over loans McClendon took out with a private equity firm. Chris Jarvis, Caprock Risk Management founder & president, also weighs in on how to play energy stocks ahead of their earnings.
A lawyer representing the bulk of claimants in the hacking case against News Corp.'s UK newspaper business said the UK company, News International, faces 46 more civil lawsuits in British courts, the Wall Street Journal reported on Friday.
Several states with dispensaries have seen an increase in both arrests and the confiscation of marijuana plants. However, a look at DEA records shows what appears to be an uneven enforcement policy among pot-friendly states over the past several years.
Sean Egan, Egan-Jones Ratings Co. president, discusses potential charges by the SEC against his company. The regulator is looking at whether the Egan-Jones made intentionally-false statements when it applied to become a nationally-recognized ratings agency in 2007.